Tag: JAK

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

Upadacitinib monotherapy is effective for patients with moderate-to-severe atopic dermatitis

byNeel Mistryand1 others

June 15, 2021

1. The proportion of patients with EASI ≥75% was significantly greater in the upadacitinib 30 mg and 15 mg groups ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation
Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
Children with intellectual and developmental disabilities have increased risks of depression and anxiety

No Result

View All Result

Tag: JAK

Upadacitinib monotherapy is effective for patients with moderate-to-severe atopic dermatitis

2MM+ All Access

Look up any US clinician

Recent Reports

The medical literature, distilled daily.

Membership benefits